SARS-CoV-2 – Medxy AI

Tomatine: A Novel Natural Adjuvant Enhancing mRNA Vaccine Efficacy in Cancer and Infectious Diseases

By MedXY 10/22/2025

Tomatine, a natural compound incorporated into mRNA vaccine nanocarriers, significantly enhances antigen expression and innate immune activation, boosting adaptive immunity against tumors and SARS-CoV-2, underscoring its potential as a versatile vaccine adjuvant.

Infectious Diseases Neurology Otorhinolaryngology Specialties

Persistent Olfactory Dysfunction Following SARS-CoV-2 Infection: Insights from the RECOVER Adult Cohort

By MedXY 10/22/2025

A large prospective study demonstrates that olfactory dysfunction is prevalent and often clinically unrecognized long after SARS-CoV-2 infection, highlighting the value of formal smell testing in patient care and cognitive risk assessment.

Infectious Diseases Public Health Specialties

Azelastine Nasal Spray Significantly Reduces SARS-CoV-2 Infection Risk: Results from a Phase 2 Randomized Clinical Trial

By MedXY 09/02/2025

This phase 2 trial demonstrates that azelastine nasal spray reduces SARS-CoV-2 infections and symptomatic respiratory illnesses in a healthy, vaccinated adult population, suggesting its potential as a safe, scalable prophylactic measure against COVID-19.

Diabetes & Endocrinology Infectious Diseases news

Impact of Obesity on Long COVID: Insights from Primate Studies

By MedXY 07/25/2025

Obesity influences the long-term effects of SARS-CoV-2, revealing diverse outcomes in primates and suggesting broader implications for humans.